| calcium channel, voltage-dependent, gamma subunit 4 | ITRACONAZOLE | Calcium Channel Type L, Benzothiazepine | 68% | NoneNone | NoneNone | View | 
          
            
                | calcium channel, voltage-dependent, gamma subunit 3 | ITRACONAZOLE | Calcium Channel Type L, Benzothiazepine | 68% | NoneNone | NoneNone | View | 
          
            
                | calcium channel, voltage-dependent, gamma subunit 2 | ITRACONAZOLE | Calcium Channel Type L, Benzothiazepine | 68% | NoneNone | NoneNone | View | 
          
            
                | calcium channel, voltage-dependent, gamma subunit 1 | ITRACONAZOLE | Calcium Channel Type L, Benzothiazepine | 68% | NoneNone | NoneNone | View | 
          
            
                | calcium channel, voltage-dependent, beta 4 subunit | ITRACONAZOLE | Calcium Channel Type L, Benzothiazepine | 68% | NoneNone | NoneNone | View | 
          
            
                | calcium channel, voltage-dependent, beta 3 subunit | ITRACONAZOLE | Calcium Channel Type L, Benzothiazepine | 68% | NoneNone | NoneNone | View | 
          
            
                | calcium channel, voltage-dependent, beta 2 subunit | ITRACONAZOLE | Calcium Channel Type L, Benzothiazepine | 68% | NoneNone | NoneNone | View | 
          
            
                | calcium channel, voltage-dependent, L type, alpha 1S subunit | ITRACONAZOLE | Calcium Channel Type L, Benzothiazepine | 68% | NoneNone | NoneNone | View | 
          
            
                | calcium channel, voltage-dependent, alpha 1F subunit | ITRACONAZOLE | Calcium Channel Type L, Benzothiazepine | 68% | NoneNone | NoneNone | View | 
          
            
                | sodium channel, voltage-gated, type II, beta | SIBUTRAMINE | Sodium Channel, Site 2 | 65% | NoneNone | NoneNone | View | 
          
            
                | sodium channel, voltage-gated, type II, alpha 2 | SIBUTRAMINE | Sodium Channel, Site 2 | 65% | NoneNone | NoneNone | View | 
          
            
                | sodium channel, voltage-gated, type I, beta | SIBUTRAMINE | Sodium Channel, Site 2 | 65% | NoneNone | NoneNone | View | 
          
            
                | sodium channel, voltage-gated, type I, alpha | SIBUTRAMINE | Sodium Channel, Site 2 | 65% | NoneNone | NoneNone | View | 
          
            
                | sodium channel, voltage-gated, type IV, beta | SIBUTRAMINE | Sodium Channel, Site 2 | 65% | NoneNone | NoneNone | View | 
          
            
                | sodium channel associated protein 1 | SIBUTRAMINE | Sodium Channel, Site 2 | 65% | NoneNone | NoneNone | View | 
          
            
                | sodium channel associated protein 2 | SIBUTRAMINE | Sodium Channel, Site 2 | 65% | NoneNone | NoneNone | View | 
          
            
                | sodium channel, voltage-gated, type III, beta | SIBUTRAMINE | Sodium Channel, Site 2 | 65% | NoneNone | NoneNone | View | 
          
            
                | sodium channel, voltage-gated, type I, alpha | SIBUTRAMINE | Sodium Channel, Site 2 | 65% | NoneNone | NoneNone | View | 
          
            
                | sodium channel, voltage-gated, type IX, alpha | SIBUTRAMINE | Sodium Channel, Site 2 | 65% | NoneNone | NoneNone | View | 
          
            
                | sodium channel, voltage-gated, type VII, alpha | SIBUTRAMINE | Sodium Channel, Site 2 | 65% | NoneNone | NoneNone | View | 
          
            
                | amiloride-sensitive cation channel 5, intestinal | SIBUTRAMINE | Sodium Channel, Site 2 | 65% | NoneNone | NoneNone | View | 
          
            
                | sodium channel, voltage-gated, type III, beta | SIBUTRAMINE | Sodium Channel, Site 2 | 65% | NoneNone | NoneNone | View | 
          
            
                | sodium channel, voltage-gated, type VIII, alpha polypeptide | SIBUTRAMINE | Sodium Channel, Site 2 | 65% | NoneNone | NoneNone | View | 
          
            
                | sodium channel, voltage-gated, type XI, alpha | SIBUTRAMINE | Sodium Channel, Site 2 | 65% | NoneNone | NoneNone | View | 
          
            
                | sodium channel, voltage-gated, type I, beta | SIBUTRAMINE | Sodium Channel, Site 2 | 65% | NoneNone | NoneNone | View | 
          
            
                | sodium channel, voltage-gated, type 10, alpha polypeptide | SIBUTRAMINE | Sodium Channel, Site 2 | 65% | NoneNone | NoneNone | View | 
          
            
                | sodium channel, voltage-gated, type IV, alpha polypeptide | SIBUTRAMINE | Sodium Channel, Site 2 | 65% | NoneNone | NoneNone | View | 
          
            
                | sodium channel, voltage-gated, type V, alpha polypeptide | SIBUTRAMINE | Sodium Channel, Site 2 | 65% | NoneNone | NoneNone | View | 
          
            
                | dopamine receptor D3 | BENZETHONIUM CHLORIDE | Dopamine D3 | 65% | NoneNone | NoneNone | View | 
          
            
                | 5-hydroxytryptamine (serotonin) receptor 1A | PHENTOLAMINE | Serotonin 5-HT1A | 65% | NoneNone | NoneNone | View | 
          
            
                | phosphodiesterase 5A, cGMP-specific | CANDESARTAN | Phosphodiesterase PDE5 | 65% | NoneNone | NoneNone | View | 
          
            
                | phosphodiesterase 5A, cGMP-specific | CANDESARTAN | Phosphodiesterase PDE5 | 65% | NoneNone | NoneNone | View | 
          
            
                | cholinergic receptor, muscarinic 1 | RALOXIFENE | Muscarinic M1 | 65% | NoneNone | NoneNone | View | 
          
            
                | Cytochrom P450-2C19 monooxygenase | RALOXIFENE | CYP450-2C19 Inhibition | 65% | NoneNone | NoneNone | View | 
          
            
                | melanocortin 3 receptor | ASTEMIZOLE | Melanocortin MC3 | 65% | 15.525uM | 13.549uM | View | 
          
            
                | melanocortin 3 receptor | ASTEMIZOLE | Melanocortin MC3 | 65% | 15.525uM | 13.549uM | View | 
          
            
                | adrenergic receptor, alpha 2a | DOXAZOSIN | Adrenergic alpha2A | 65% | NoneNone | NoneNone | View | 
          
            
                | calcium channel, voltage-dependent, gamma subunit 8 | EMETINE | Calcium Channel Type L, Phenylalkylamine | 65% | NoneNone | NoneNone | View | 
          
            
                | calcium channel, voltage-dependent, gamma subunit 7 | EMETINE | Calcium Channel Type L, Phenylalkylamine | 65% | NoneNone | NoneNone | View | 
          
            
                | calcium channel, voltage-dependent, gamma subunit 6 | EMETINE | Calcium Channel Type L, Phenylalkylamine | 65% | NoneNone | NoneNone | View | 
          
            
                | calcium channel, voltage-dependent, gamma subunit 5 | EMETINE | Calcium Channel Type L, Phenylalkylamine | 65% | NoneNone | NoneNone | View | 
          
            
                | calcium channel, voltage-dependent, gamma subunit 4 | EMETINE | Calcium Channel Type L, Phenylalkylamine | 65% | NoneNone | NoneNone | View | 
          
            
                | calcium channel, voltage-dependent, gamma subunit 3 | EMETINE | Calcium Channel Type L, Phenylalkylamine | 65% | NoneNone | NoneNone | View | 
          
            
                | calcium channel, voltage-dependent, gamma subunit 2 | EMETINE | Calcium Channel Type L, Phenylalkylamine | 65% | NoneNone | NoneNone | View | 
          
            
                | calcium channel, voltage-dependent, gamma subunit 1 | EMETINE | Calcium Channel Type L, Phenylalkylamine | 65% | NoneNone | NoneNone | View | 
          
            
                | calcium channel, voltage-dependent, beta 4 subunit | EMETINE | Calcium Channel Type L, Phenylalkylamine | 65% | NoneNone | NoneNone | View | 
          
            
                | calcium channel, voltage-dependent, beta 3 subunit | EMETINE | Calcium Channel Type L, Phenylalkylamine | 65% | NoneNone | NoneNone | View | 
          
            
                | calcium channel, voltage-dependent, beta 2 subunit | EMETINE | Calcium Channel Type L, Phenylalkylamine | 65% | NoneNone | NoneNone | View | 
          
            
                | calcium channel, voltage-dependent, L type, alpha 1S subunit | EMETINE | Calcium Channel Type L, Phenylalkylamine | 65% | NoneNone | NoneNone | View | 
          
            
                | calcium channel, voltage-dependent, alpha 1F subunit | EMETINE | Calcium Channel Type L, Phenylalkylamine | 65% | NoneNone | NoneNone | View | 
          
            
                | adenosine A2a receptor | ALPHA-NAPHTHOFLAVONE | Adenosine A2A | 65% | NoneNone | NoneNone | View | 
          
            
                | v-erb-b2 erythroblastic leukemia viral oncogene homolog 2, neuro/glioblastoma derived oncogene homolog (avian) | PACLITAXEL | Protein Tyrosine Kinase, HER2 Receptor | 65% | 11.108uM | NoneNone | View | 
          
            
                | v-erb-b2 erythroblastic leukemia viral oncogene homolog 2, neuro/glioblastoma derived oncogene homolog (avian) | PACLITAXEL | Protein Tyrosine Kinase, HER2 Receptor | 65% | 11.108uM | NoneNone | View | 
          
            
                | adenosine A2a receptor | CLOTRIMAZOLE | Adenosine A2A | 65% | 12.711uM | 7.136uM | View | 
          
            
                | Cytochrom P450-2D6 monooxygenase | CHLORPROMAZINE | CYP450-2D6 Inhibition | 65% | NoneNone | NoneNone | View | 
          
            
                | Protein-tyrosine kinase, Fyn | CATECHOL | Protein Tyrosine Kinase, Fyn | 65% | 17.431uM | NoneNone | View | 
          
            
                | adrenergic receptor, alpha 2b | CYCLIZINE | Adrenergic alpha2B | 65% | NoneNone | NoneNone | View | 
          
            
                | adenosine A2a receptor | THEOPHYLLINE | Adenosine A2A | 65% | 12.007uM | 6.741uM | View | 
          
            
                | adenosine A1 receptor | THEOPHYLLINE | Adenosine A1 | 65% | 17.104uM | 9.977uM | View | 
          
            
                | cholinergic receptor, muscarinic 4 | FLUOXETINE | Muscarinic M4 | 65% | NoneNone | NoneNone | View | 
          
            
                | adrenergic receptor, alpha 2b | FLAVOXATE | Adrenergic alpha2C | 65% | NoneNone | NoneNone | View | 
          
            
                | adrenergic receptor, alpha 2c (Non-specific probe) | FLAVOXATE | Adrenergic alpha2C | 65% | NoneNone | NoneNone | View | 
          
            
                | Cytochrom P450-2D6 monooxygenase | HALOPERIDOL | CYP450-2D6 Inhibition | 65% | NoneNone | NoneNone | View | 
          
            
                | Cytochrom P450-2C19 monooxygenase | LETROZOLE | CYP450-2C19 Inhibition | 65% | NoneNone | NoneNone | View | 
          
            
                | phosphodiesterase 3B | GENISTEIN | Phosphodiesterase PDE3 | 65% | 11.013uM | NoneNone | View | 
          
            
                | phosphodiesterase 3A | GENISTEIN | Phosphodiesterase PDE3 | 65% | 11.013uM | NoneNone | View | 
          
            
                | calcium channel, voltage-dependent, N type, alpha 1B subunit | TRIHEXYPHENIDYL | Calcium Channel Type L, Benzothiazepine | 70% | 4.81uM | 4.275uM | View | 
          
            
                | calcium channel, voltage-dependent, beta 2 subunit | CLOTRIMAZOLE | Calcium Channel Type L, Benzothiazepine | 70% | 28.499uM | 25.332uM | View | 
          
            
                | calcium channel, voltage-dependent, L type, alpha 1S subunit | CLOTRIMAZOLE | Calcium Channel Type L, Benzothiazepine | 70% | 28.499uM | 25.332uM | View | 
          
            
                | calcium channel, voltage-dependent, alpha 1F subunit | CLOTRIMAZOLE | Calcium Channel Type L, Benzothiazepine | 70% | 28.499uM | 25.332uM | View | 
          
            
                | calcium channel, voltage-dependent, L type, alpha 1D subunit | CLOTRIMAZOLE | Calcium Channel Type L, Benzothiazepine | 70% | 28.499uM | 25.332uM | View | 
          
            
                | calcium channel, voltage-dependent, L type, alpha 1C subunit | CLOTRIMAZOLE | Calcium Channel Type L, Benzothiazepine | 70% | 28.499uM | 25.332uM | View | 
          
            
                | calcium channel, voltage-dependent, P/Q type, alpha 1A subunit | CLOTRIMAZOLE | Calcium Channel Type L, Benzothiazepine | 70% | 28.499uM | 25.332uM | View | 
          
            
                | calcium channel, voltage-dependent, beta 1 subunit | CLOTRIMAZOLE | Calcium Channel Type L, Benzothiazepine | 70% | 28.499uM | 25.332uM | View | 
          
            
                | calcium channel, voltage-dependent, L type, alpha 1E subunit | CLOTRIMAZOLE | Calcium Channel Type L, Benzothiazepine | 70% | 28.499uM | 25.332uM | View | 
          
            
                | calcium channel, voltage-dependent, N type, alpha 1B subunit | CLOTRIMAZOLE | Calcium Channel Type L, Benzothiazepine | 70% | 28.499uM | 25.332uM | View | 
          
            
                | calcium channel, voltage-dependent, alpha2/delta subunit 1 | CLOTRIMAZOLE | Calcium Channel Type L, Benzothiazepine | 70% | 28.499uM | 25.332uM | View | 
          
            
                | acetylcholinesterase (YT blood group) | CLOTRIMAZOLE | Acetylcholinesterase | 70% | 19.41uM | NoneNone | View | 
          
            
                | collagen-like tail subunit (single strand of homotrimer) of asymmetric acetylcholinesterase | CLOTRIMAZOLE | Acetylcholinesterase | 70% | 19.41uM | NoneNone | View | 
          
            
                | acetylcholinesterase | CLOTRIMAZOLE | Acetylcholinesterase | 70% | 19.41uM | NoneNone | View | 
          
            
                | adrenergic receptor, beta 3 | AMIODARONE | Adrenergic beta3 | 70% | 42.349uM | 31.761uM | View | 
          
            
                | 5-hydroxytryptamine (serotonin) receptor 2B | TRETINOIN | Serotonin 5-HT2B | 70% | .358uM | .228uM | View | 
          
            
                | cytochrome P450, family 3, subfamily a, polypeptide 13 | DIHYDROERGOTAMINE | CYP450-3A4 Inhibition | 70% | 5uM | NoneNone | View | 
          
            
                | opioid receptor, kappa 1 | BISACODYL | Opiate kappa | 70% | 2.437uM | .975uM | View | 
          
            
                | adrenergic receptor, alpha 1a | BRIMONIDINE | Adrenergic alpha1A | 70% | 6.344uM | 2.568uM | View | 
          
            
                | adrenergic receptor, alpha 1d (Non-specific probe) | BRIMONIDINE | Adrenergic alpha1D | 70% | 1.72uM | .846uM | View | 
          
            
                | cholinergic receptor, muscarinic 2 | FLUPHENAZINE | Muscarinic M2 | 70% | 7.481uM | 2.66uM | View | 
          
            
                | melanocortin 5 receptor | BENZOTHIAZYL DISULFIDE | Melanocortin MC5 | 70% | 3.9uM | 3.7uM | View | 
          
            
                | solute carrier family 6 (neurotransmitter transporter, noradrenalin), member 2 | CAFFEIC ACID PHENETHYL ESTER | Adrenergic, Norepinephrine Transporter | 70% | 3.787uM | 3.756uM | View | 
          
            
                | arachidonate 15-lipoxygenase, second type | TOLAZAMIDE | Lipoxygenase 15-LO | 70% | 5.106uM | NoneNone | View | 
          
            
                | arachidonate 15-lipoxygenase | TOLAZAMIDE | Lipoxygenase 15-LO | 70% | 5.106uM | NoneNone | View | 
          
            
                | arachidonate 15-lipoxygenase | TOLAZAMIDE | Lipoxygenase 15-LO | 70% | 5.106uM | NoneNone | View | 
          
            
                | 5-hydroxytryptamine (serotonin) receptor 2B | LABETALOL | Serotonin 5-HT2B | 70% | 3.037uM | 1.933uM | View | 
          
            
                | mu-opioid receptor MOR | HALOPERIDOL | Opiate mu | 70% | 2.443uM | .992uM | View | 
          
            
                | cathepsin G | TRIAMTERENE | Protease, Cathepsin G | 70% | 7.413uM | NoneNone | View | 
          
            
                | mast cell protease 9 | TRIAMTERENE | Protease, Cathepsin G | 70% | 7.413uM | NoneNone | View | 
          
            
                | A3 adenosine receptor | CISPLATIN | Adenosine A3 | 70% | 4.243uM | 2.398uM | View | 
          
            
                | adrenergic receptor, alpha 1d (Non-specific probe) | CITALOPRAM | Adrenergic alpha1D | 70% | 3.289uM | 1.617uM | View | 
          
            
                | 5-hydroxytryptamine (serotonin) receptor 2B | MEPAZINE | Serotonin 5-HT2B | 70% | .514uM | .327uM | View | 
          
            
                | Cytochrom P450-1A2 monooxygenase | PHENYLHYDRAZINE | CYP450-1A2 Inhibition | 70% | 8uM | NoneNone | View | 
          
            
                | calcium channel, voltage-dependent, gamma subunit 2 | L-744832 | Calcium Channel Type L, Dihydropyridine | 70% | 4.501uM | 2.893uM | View | 
          
            
                | calcium channel, voltage-dependent, gamma subunit 1 | L-744832 | Calcium Channel Type L, Dihydropyridine | 70% | 4.501uM | 2.893uM | View | 
          
            
                | calcium channel, voltage-dependent, beta 4 subunit | L-744832 | Calcium Channel Type L, Dihydropyridine | 70% | 4.501uM | 2.893uM | View | 
          
            
                | calcium channel, voltage-dependent, beta 3 subunit | L-744832 | Calcium Channel Type L, Dihydropyridine | 70% | 4.501uM | 2.893uM | View | 
          
            
                | calcium channel, voltage-dependent, beta 2 subunit | L-744832 | Calcium Channel Type L, Dihydropyridine | 70% | 4.501uM | 2.893uM | View | 
          
            
                | calcium channel, voltage-dependent, L type, alpha 1S subunit | L-744832 | Calcium Channel Type L, Dihydropyridine | 70% | 4.501uM | 2.893uM | View | 
          
            
                | calcium channel, voltage-dependent, alpha 1F subunit | L-744832 | Calcium Channel Type L, Dihydropyridine | 70% | 4.501uM | 2.893uM | View | 
          
            
                | calcium channel, voltage-dependent, L type, alpha 1D subunit | L-744832 | Calcium Channel Type L, Dihydropyridine | 70% | 4.501uM | 2.893uM | View | 
          
            
                | calcium channel, voltage-dependent, L type, alpha 1C subunit | L-744832 | Calcium Channel Type L, Dihydropyridine | 70% | 4.501uM | 2.893uM | View | 
          
            
                | calcium channel, voltage-dependent, P/Q type, alpha 1A subunit | L-744832 | Calcium Channel Type L, Dihydropyridine | 70% | 4.501uM | 2.893uM | View | 
          
            
                | calcium channel, voltage-dependent, beta 1 subunit | L-744832 | Calcium Channel Type L, Dihydropyridine | 70% | 4.501uM | 2.893uM | View | 
          
            
                | calcium channel, voltage-dependent, L type, alpha 1E subunit | L-744832 | Calcium Channel Type L, Dihydropyridine | 70% | 4.501uM | 2.893uM | View | 
          
            
                | calcium channel, voltage-dependent, N type, alpha 1B subunit | L-744832 | Calcium Channel Type L, Dihydropyridine | 70% | 4.501uM | 2.893uM | View | 
          
            
                | calcium channel, voltage-dependent, alpha2/delta subunit 1 | L-744832 | Calcium Channel Type L, Dihydropyridine | 70% | 4.501uM | 2.893uM | View | 
          
            
                | calcium channel, voltage-dependent, gamma subunit 8 | L-744832 | Calcium Channel Type L, Dihydropyridine | 70% | 4.501uM | 2.893uM | View | 
          
            
                | calcium channel, voltage-dependent, gamma subunit 7 | L-744832 | Calcium Channel Type L, Dihydropyridine | 70% | 4.501uM | 2.893uM | View | 
          
            
                | calcium channel, voltage-dependent, L type, alpha 1D subunit | ITRACONAZOLE | Calcium Channel Type L, Benzothiazepine | 68% | NoneNone | NoneNone | View | 
          
            
                | calcium channel, voltage-dependent, L type, alpha 1C subunit | ITRACONAZOLE | Calcium Channel Type L, Benzothiazepine | 68% | NoneNone | NoneNone | View | 
          
            
                | calcium channel, voltage-dependent, P/Q type, alpha 1A subunit | ITRACONAZOLE | Calcium Channel Type L, Benzothiazepine | 68% | NoneNone | NoneNone | View | 
          
            
                | calcium channel, voltage-dependent, beta 1 subunit | ITRACONAZOLE | Calcium Channel Type L, Benzothiazepine | 68% | NoneNone | NoneNone | View | 
          
            
                | calcium channel, voltage-dependent, L type, alpha 1E subunit | ITRACONAZOLE | Calcium Channel Type L, Benzothiazepine | 68% | NoneNone | NoneNone | View | 
          
            
                | calcium channel, voltage-dependent, N type, alpha 1B subunit | ITRACONAZOLE | Calcium Channel Type L, Benzothiazepine | 68% | NoneNone | NoneNone | View | 
          
            
                | calcium channel, voltage-dependent, alpha2/delta subunit 1 | ITRACONAZOLE | Calcium Channel Type L, Benzothiazepine | 68% | NoneNone | NoneNone | View | 
          
            
                | melanocortin 4 receptor | RESERPINE | Melanocortin MC4 | 68% | NoneNone | NoneNone | View | 
          
            
                | dopamine receptor D3 | OXYMETAZOLINE | Dopamine D3 | 68% | NoneNone | NoneNone | View | 
          
            
                | melanocortin 5 receptor | EBASTINE | Melanocortin MC5 | 68% | NoneNone | NoneNone | View | 
          
            
                | 5-hydroxytryptamine (serotonin) receptor 1B | DAPIPRAZOLE | Serotonin 5-HT1B | 68% | NoneNone | NoneNone | View | 
          
            
                | adrenergic receptor, alpha 2b | DAPIPRAZOLE | Adrenergic alpha2C | 68% | NoneNone | NoneNone | View | 
          
            
                | adrenergic receptor, alpha 2c (Non-specific probe) | DAPIPRAZOLE | Adrenergic alpha2C | 68% | NoneNone | NoneNone | View | 
          
            
                | cholinergic receptor, muscarinic 4 | RALOXIFENE | Muscarinic M4 | 68% | NoneNone | NoneNone | View | 
          
            
                | adrenergic receptor, alpha 2a | DAPIPRAZOLE | Adrenergic alpha2A | 68% | NoneNone | NoneNone | View | 
          
            
                | prostaglandin-endoperoxide synthase 2 | TRIBROMSALAN | Cyclooxygenase COX-2 | 68% | NoneNone | NoneNone | View | 
          
            
                | prostaglandin-endoperoxide synthase 2 (prostaglandin G/H synthase and cyclooxygenase) | TRIBROMSALAN | Cyclooxygenase COX-2 | 68% | NoneNone | NoneNone | View | 
          
            
                | adrenergic receptor, alpha 2b | KETOCONAZOLE | Adrenergic alpha2B | 68% | 18.047uM | 8.239uM | View | 
          
            
                | thromboxane A synthase 1 | METYRAPONE | Thromboxane Synthetase | 68% | NoneNone | NoneNone | View | 
          
            
                | thromboxane A synthase 1 (platelet, cytochrome P450, family 5, subfamily A) | METYRAPONE | Thromboxane Synthetase | 68% | NoneNone | NoneNone | View | 
          
            
                | cholinergic receptor, muscarinic 2 | SULCONAZOLE | Muscarinic M2 | 68% | NoneNone | NoneNone | View | 
          
            
                | calcium channel, voltage-dependent, gamma subunit 8 | DANAZOL | Calcium Channel Type L, Phenylalkylamine | 68% | 14.61uM | 14.198uM | View | 
          
            
                | calcium channel, voltage-dependent, gamma subunit 7 | DANAZOL | Calcium Channel Type L, Phenylalkylamine | 68% | 14.61uM | 14.198uM | View | 
          
            
                | calcium channel, voltage-dependent, gamma subunit 6 | DANAZOL | Calcium Channel Type L, Phenylalkylamine | 68% | 14.61uM | 14.198uM | View | 
          
            
                | calcium channel, voltage-dependent, gamma subunit 5 | DANAZOL | Calcium Channel Type L, Phenylalkylamine | 68% | 14.61uM | 14.198uM | View | 
          
            
                | calcium channel, voltage-dependent, gamma subunit 4 | DANAZOL | Calcium Channel Type L, Phenylalkylamine | 68% | 14.61uM | 14.198uM | View | 
          
            
                | calcium channel, voltage-dependent, gamma subunit 3 | DANAZOL | Calcium Channel Type L, Phenylalkylamine | 68% | 14.61uM | 14.198uM | View | 
          
            
                | calcium channel, voltage-dependent, gamma subunit 2 | DANAZOL | Calcium Channel Type L, Phenylalkylamine | 68% | 14.61uM | 14.198uM | View | 
          
            
                | calcium channel, voltage-dependent, gamma subunit 1 | DANAZOL | Calcium Channel Type L, Phenylalkylamine | 68% | 14.61uM | 14.198uM | View | 
          
            
                | calcium channel, voltage-dependent, beta 4 subunit | DANAZOL | Calcium Channel Type L, Phenylalkylamine | 68% | 14.61uM | 14.198uM | View | 
          
            
                | calcium channel, voltage-dependent, beta 3 subunit | DANAZOL | Calcium Channel Type L, Phenylalkylamine | 68% | 14.61uM | 14.198uM | View | 
          
            
                | calcium channel, voltage-dependent, beta 2 subunit | DANAZOL | Calcium Channel Type L, Phenylalkylamine | 68% | 14.61uM | 14.198uM | View | 
          
            
                | calcium channel, voltage-dependent, L type, alpha 1S subunit | DANAZOL | Calcium Channel Type L, Phenylalkylamine | 68% | 14.61uM | 14.198uM | View | 
          
            
                | calcium channel, voltage-dependent, alpha 1F subunit | DANAZOL | Calcium Channel Type L, Phenylalkylamine | 68% | 14.61uM | 14.198uM | View | 
          
            
                | calcium channel, voltage-dependent, L type, alpha 1D subunit | DANAZOL | Calcium Channel Type L, Phenylalkylamine | 68% | 14.61uM | 14.198uM | View | 
          
            
                | calcium channel, voltage-dependent, L type, alpha 1C subunit | DANAZOL | Calcium Channel Type L, Phenylalkylamine | 68% | 14.61uM | 14.198uM | View | 
          
            
                | calcium channel, voltage-dependent, P/Q type, alpha 1A subunit | DANAZOL | Calcium Channel Type L, Phenylalkylamine | 68% | 14.61uM | 14.198uM | View | 
          
            
                | calcium channel, voltage-dependent, beta 1 subunit | DANAZOL | Calcium Channel Type L, Phenylalkylamine | 68% | 14.61uM | 14.198uM | View | 
          
            
                | calcium channel, voltage-dependent, L type, alpha 1E subunit | DANAZOL | Calcium Channel Type L, Phenylalkylamine | 68% | 14.61uM | 14.198uM | View | 
          
            
                | calcium channel, voltage-dependent, N type, alpha 1B subunit | DANAZOL | Calcium Channel Type L, Phenylalkylamine | 68% | 14.61uM | 14.198uM | View | 
          
            
                | calcium channel, voltage-dependent, alpha2/delta subunit 1 | DANAZOL | Calcium Channel Type L, Phenylalkylamine | 68% | 14.61uM | 14.198uM | View | 
          
            
                | acetylcholinesterase (YT blood group) | DIETHYLSTILBESTROL | Acetylcholinesterase | 68% | 25.55uM | NoneNone | View | 
          
            
                | collagen-like tail subunit (single strand of homotrimer) of asymmetric acetylcholinesterase | DIETHYLSTILBESTROL | Acetylcholinesterase | 68% | 25.55uM | NoneNone | View | 
          
            
                | acetylcholinesterase | DIETHYLSTILBESTROL | Acetylcholinesterase | 68% | 25.55uM | NoneNone | View | 
          
            
                | 5-hydroxytryptamine (serotonin) receptor 5B | FLUTAMIDE | Serotonin 5-HT4 | 68% | 13.545uM | 2.258uM | View | 
          
            
                | 5-hydroxytryptamine (serotonin) receptor 4 | FLUTAMIDE | Serotonin 5-HT4 | 68% | 13.545uM | 2.258uM | View | 
          
            
                | androgen receptor | BACITRACIN | Testosterone | 68% | NoneNone | NoneNone | View | 
          
            
                | androgen receptor | RAPAMYCIN | Testosterone | 68% | NoneNone | NoneNone | View | 
          
            
                | 5-hydroxytryptamine (serotonin) receptor 2A | TIRILAZAD | Serotonin 5-HT2A | 68% | 2.002uM | .572uM | View | 
          
            
                | phosphodiesterase 4C, cAMP-specific | CELECOXIB | Phosphodiesterase PDE4 | 68% | 9.26uM | NoneNone | View | 
          
            
                | phosphodiesterase 4D | CELECOXIB | Phosphodiesterase PDE4 | 68% | 9.26uM | NoneNone | View | 
          
            
                | phosphodiesterase 4B, cAMP specific | CELECOXIB | Phosphodiesterase PDE4 | 68% | 9.26uM | NoneNone | View | 
          
            
                | calcium channel, voltage-dependent, gamma subunit 8 | DEXTROMETHORPHAN | Calcium Channel Type L, Benzothiazepine | 66% | NoneNone | NoneNone | View | 
          
            
                | calcium channel, voltage-dependent, gamma subunit 7 | DEXTROMETHORPHAN | Calcium Channel Type L, Benzothiazepine | 66% | NoneNone | NoneNone | View | 
          
            
                | calcium channel, voltage-dependent, gamma subunit 6 | DEXTROMETHORPHAN | Calcium Channel Type L, Benzothiazepine | 66% | NoneNone | NoneNone | View | 
          
            
                | sodium channel associated protein 1 | PUROMYCIN | Sodium Channel, Site 2 | 12% | NoneNone | NoneNone | View | 
          
            
                | calcium channel, voltage-dependent, gamma subunit 5 | DEXTROMETHORPHAN | Calcium Channel Type L, Benzothiazepine | 66% | NoneNone | NoneNone | View | 
          
            
                | calcium channel, voltage-dependent, gamma subunit 4 | DEXTROMETHORPHAN | Calcium Channel Type L, Benzothiazepine | 66% | NoneNone | NoneNone | View | 
          
            
                | calcium channel, voltage-dependent, gamma subunit 3 | DEXTROMETHORPHAN | Calcium Channel Type L, Benzothiazepine | 66% | NoneNone | NoneNone | View | 
          
            
                | calcium channel, voltage-dependent, gamma subunit 2 | DEXTROMETHORPHAN | Calcium Channel Type L, Benzothiazepine | 66% | NoneNone | NoneNone | View | 
          
            
                | calcium channel, voltage-dependent, gamma subunit 1 | DEXTROMETHORPHAN | Calcium Channel Type L, Benzothiazepine | 66% | NoneNone | NoneNone | View | 
          
            
                | cholinergic receptor, muscarinic 1 | ALPHA-NAPHTHOFLAVONE | Muscarinic M1 | 66% | NoneNone | NoneNone | View | 
          
            
                | ATPase, Na+/K+ transporting, alpha 4 polypeptide | TRANS-PLATINUM(II)DIAMMINE DICHLORIDE | ATPase, Na+/K+ | 66% | NoneNone | NoneNone | View | 
          
            
                | ATPase, Na+/K+ transporting, alpha 3 polypeptide | TRANS-PLATINUM(II)DIAMMINE DICHLORIDE | ATPase, Na+/K+ | 66% | NoneNone | NoneNone | View | 
          
            
                | ATPase, Na+/K+ transporting, alpha 2 polypeptide | TRANS-PLATINUM(II)DIAMMINE DICHLORIDE | ATPase, Na+/K+ | 66% | NoneNone | NoneNone | View | 
          
            
                | ATPase, Na+/K+ transporting, alpha 1 polypeptide | TRANS-PLATINUM(II)DIAMMINE DICHLORIDE | ATPase, Na+/K+ | 66% | NoneNone | NoneNone | View | 
          
            
                | ATPase, Na+/K+ transporting, beta 1 polypeptide | TRANS-PLATINUM(II)DIAMMINE DICHLORIDE | ATPase, Na+/K+ | 66% | NoneNone | NoneNone | View | 
          
            
                | ATPase, Na+/K+ transporting, beta 3 polypeptide | TRANS-PLATINUM(II)DIAMMINE DICHLORIDE | ATPase, Na+/K+ | 66% | NoneNone | NoneNone | View | 
          
            
                | ATPase, Na+/K+ transporting, beta 2 polypeptide | TRANS-PLATINUM(II)DIAMMINE DICHLORIDE | ATPase, Na+/K+ | 66% | NoneNone | NoneNone | View | 
          
            
                | ATPase, (Na+)/K+ transporting, beta 4 polypeptide | TRANS-PLATINUM(II)DIAMMINE DICHLORIDE | ATPase, Na+/K+ | 66% | NoneNone | NoneNone | View | 
          
            
                | dopamine receptor D3 | EPINEPHRINE | Dopamine D3 | 66% | NoneNone | NoneNone | View | 
          
            
                | dopamine receptor D1A | CINNARIZINE | Dopamine D1 | 66% | NoneNone | NoneNone | View | 
          
            
                | cytochrome P450, family 3, subfamily a, polypeptide 13 | CLEMASTINE | CYP450-3A4 Inhibition | 66% | NoneNone | NoneNone | View | 
          
            
                | Cytochrom P450-2D6 monooxygenase | OXYBUTYNIN | CYP450-2D6 Inhibition | 66% | NoneNone | NoneNone | View | 
          
            
                | Cytochrom P450-2D6 monooxygenase | SERTRALINE | CYP450-2D6 Inhibition | 66% | NoneNone | NoneNone | View | 
          
            
                | Cytochrom P450-2D6 monooxygenase | AZTREONAM | CYP450-2D6 Inhibition | 66% | NoneNone | NoneNone | View | 
          
            
                | A3 adenosine receptor | ALFACALCIDOL | Adenosine A3 | 66% | NoneNone | NoneNone | View | 
          
            
                | aldo-keto reductase family 1, member B4 (aldose reductase) | ACEMETACIN | Aldose Reductase | 66% | NoneNone | NoneNone | View | 
          
            
                | aldo-keto reductase family 1, member B1 (aldose reductase) | ACEMETACIN | Aldose Reductase | 66% | NoneNone | NoneNone | View | 
          
            
                | aldo-keto reductase family 7, member A2 (aflatoxin aldehyde reductase) | ACEMETACIN | Aldose Reductase | 66% | NoneNone | NoneNone | View | 
          
            
                | aldo-keto reductase family 7, member A3 (aflatoxin aldehyde reductase) | ACEMETACIN | Aldose Reductase | 66% | NoneNone | NoneNone | View | 
          
            
                | calcium channel, voltage-dependent, gamma subunit 8 | DIPHENIDOL | Calcium Channel Type L, Benzothiazepine | 66% | NoneNone | NoneNone | View | 
          
            
                | calcium channel, voltage-dependent, gamma subunit 7 | DIPHENIDOL | Calcium Channel Type L, Benzothiazepine | 66% | NoneNone | NoneNone | View | 
          
            
                | calcium channel, voltage-dependent, gamma subunit 6 | DIPHENIDOL | Calcium Channel Type L, Benzothiazepine | 66% | NoneNone | NoneNone | View |